|
Originally published In Press as doi:10.1074/jbc.M001112200 on July 19, 2000
J. Biol. Chem., Vol. 275, Issue 39, 30287-30292, September 29, 2000
Bacillus subtilis YqkI Is a Novel
Malic/Na+-Lactate Antiporter That Enhances Growth on Malate
at Low Protonmotive Force*
Yi
Wei ,
Arthur A.
Guffanti ,
Masahiro
Ito§, and
Terry A.
Krulwich ¶
From the Department of Biochemistry and Molecular
Biology, Mount Sinai School of Medicine, New York, New York 10029 and § Department of Life Science, Toyo University,
Oura-gun, Gunma 374-0193, Japan
Received for publication, February 10, 2000, and in revised form, June 25, 2000
 |
ABSTRACT |
Bacillus subtilis yheL encodes a
Na+/H+ antiporter, whereas its paralogue,
yqkI, encodes a novel antiporter that achieves a simultaneous Na+/H+ and malolactate
antiport. B. subtilis yufR, a control in some experiments, encodes a Na+/malate symporter. YqkI
complemented a malate transport mutant of Escherichia coli
if Na+ and lactate were present. YheL conferred
Na+ uptake capacity on everted membrane vesicles from an
antiporter-deficient E. coli mutant that was consistent
with a secondary Na+/H+ antiport, but
YqkI-dependent Na+ uptake depended on
intravesicular malate and extravesicular lactate. YqkI-dependent lactate uptake depended on intravesicular
malate and extravesicular Na+. YqkI mediated an
electroneutral exchange, which is proposed to be a
malic 2-2H+ (or fully protonated
malate)/Na+-lactate 1 antiport. Because the
composite YqkI-mediated exchanges could be driven by gradients of the
malate-lactate pair, this transporter could play a role in growth of
B. subtilis on malate at low protonmotive force. A mutant
with a disruption of yqkI exhibited an abrupt arrest in the
mid-logarithmic phase of growth on malate when low concentrations of
protonophore were present. Thus growth of B. subtilis to
high density on a putatively nonfermentative dicarboxylic acid
substrate depends on a malolactate exchange at suboptimal protonmotive force.
 |
INTRODUCTION |
The catalogue of diverse structural and mechanistic types of
Na+ efflux systems in prokaryotes is still expanding
rapidly, an eloquent testimony to the importance of maintaining low
cytoplasmic concentrations of Na+ (1-3). Those
Na+ efflux systems which are secondary active transport
systems are dominated thus far by Na+/H+
antiporters (3, 4). They are energized by the electrochemical proton
gradient, p1, that is
produced by distinct redox-, light-, or ATP-driven proton extrusion
systems (5, 6). These antiporters sometimes catalyze efflux of
Li+ and/or K+ in addition to Na+
and thus can have a role in Li+ resistance and
K+ homeostasis, respectively, as well as in Na+
resistance (7). Na+/H+ antiporters can support
net accumulation of H+ when the coupling ratio of
H+/Na+ is greater than unity (8). Accordingly,
they can also contribute importantly to pH homeostasis when cells are
growing in alkaline media (7, 9, 10). However, reliance on these
mechanisms makes these important stress responses vulnerable to
conditions in which the p is low, i.e. at which the
driving force for the secondary antiporters is reduced.
At the level of amino acid sequence and likely structural category, the
secondary Na+/H+ antiporters reported to date
are all distinct from one another except for orthologues, which are
simply closely related gene products in different organisms (3). The
diversity of the proteins that catalyze Na+/H+
antiport indicates that there is flexibility in the structures that can
support this particular transport function and in some instances
reflects a capacity for transporting additional substrates (3, 9). The
current study focuses on two paralogous Bacillus subtilis
genes whose deduced products both have strong sequence similarity to
the Na+/H+ antiporter NhaC. NhaC was first
described in alkaliphilic Bacillus pseudofirmus OF4
(formerly B. firmus OF4 (11)) (12, 13). In that organism,
NhaC appears to be one of the relatively high affinity
Na+/H+ antiporters with a role in pH
homeostasis at high pH and low [Na+] but no evident role
in resistance to growth inhibition by elevated Na+ (13).
Expression of the two homologous B. subtilis genes,
yheL and yqkI, was recently examined in
tetA(L) deletion mutants of B. subtilis to
ascertain whether their up-regulation might occur upon loss of the
Na+/H+ antiporter function of multifunctional
TetA(L) (14). Expression of one of these genes, yheL, was
indeed up-regulated. In addition, B. subtilis mutants
deleted in yheL had a phenotype consistent with YheL being
an NhaC-type of Na+/H+ antiporter. The
experiments reported here were subsequently undertaken to confirm that
YheL indeed catalyzed this exchange and to probe the possibility that
the product of the other paralogue, yqkI, whose expression
was not up-regulated, might catalyze a different, novel exchange.
The genomic context of yqkI provided an interesting clue to
such an alternative exchange. The yqkI gene is in an
apparent operon with yqkJ. The strongly predicted product of
yqkJ in BLAST (15) analyses is a malolactate enzyme. The
malolactate enzymes of lactic acid bacteria catalyze the formation of
lactate and carbon dioxide from malate, with the consumption of a
cytoplasmic proton (16, 17). The malolactate enzyme, together with a
transporter (or two separate transporters) that exchanges the external
precursor (malate) for the product of the malolactate enzyme (lactate), comprise malolactate fermentation (MLF) (18, 19). MLF plays an
important role in determining the acidity of wine (20-22). The basis
for energy conservation for the bacteria that carry out the MLF pathway
depends in part on the consumption of the cytoplasmic proton, so that a
net pH, acid outside, results (17). Depending on the details
of substrate and product exchange, energy conservation may be further
enhanced (18, 19, 23), e.g. as in Lactobacillus lactis in which the malate-lactate exchange catalyzed by an
antiporter is accompanied by inward movement of net negative charge,
producing  (24). The deduced yqkI product does not
resemble the malolactate exchange transporters or malate transporters
that have been described in association with malolactate enzymes in
fermentative bacteria (24-26).
The current study was designed to test the possibility that in fact
YqkI is a novel transporter that combines
Na+/H+ and malate/lactate antiports in a
malate-proton/Na-lactate exchange. Comparisons were carried out on the
YheL-, YqkI-, and YufR-mediated transport activities in cells of a
malate-minus Escherichia coli strain and in membrane
vesicles from a Na+/H+ antiporter-deficient
E. coli strain. YufR is a distinct B. subtilis transport protein of unconfirmed function that was strongly predicted by both sequence and context to encode a Na+/malate
symporter and hence was developed as a positive control for some of the
experiments. The results support the expected catalytic properties for
YheL and YufR and support the proposal that YqkI is a new structural
type of malate/lactate antiporter that has novel ion coupling
properties, i.e. coupling Na+ efflux and
H+ uptake to the substrate-product antiport. Because the
concentration gradients of the organic acid substrate and product could
drive the coupled antiport, this combined exchange could be less
vulnerable to reductions in the p such as those accompanying
increased cell densities or encounters with protonophoric agents.
Studies of a mutant in which yqkI was disrupted support this hypothesis.
 |
EXPERIMENTAL PROCEDURES |
Bacterial Strains and Plasmids--
Three E. coli
strains were used in this study: E. coli strain DH5a (Life
Technologies, Inc.) was used for initial cloning work; E. coli EP432 (27), a
Na+/H+-antiporter-deficient strain; and
E. coli CBT312 (28), which is deficient in malic acid
transport. The E. coli strains were grown at 37 °C in the
media described in connection with specific experiments. Two strains of
B. subtilis were employed, the wild type, BD99 strain
obtained from A. Garro, and the VK3 strain constructed as part of this
study. The cells were grown at 37 °C in Spizizen salts medium with
either glucose or malate as the major carbon source, as described
previously (14).
The plasmid constructs were made by cloning PCR products into shuttle
vector pBK36 (obtained from K. Zen). The primers and sites used for
cloning the genes are listed in Table I.
The various plasmids are designated pBK36 (control plasmid),
pYqkI, pYqkJ, pYqkIJ, pYufR, and pYheL.
Complementation and Resistance Studies in E. coli--
The
complementation of E. coli EP432 by the different plasmid
constructs was tested as described previously (29) in LBK medium (30),
supplemented with various concentrations of NaCl. In some experiments
50% LBK plus either 50 mM potassium malate or glucose was
used. Complementation of E. coli CBT312 for growth on malate
was tested in two ways. In one protocol, LT medium (26) containing
L-malate and bromcresol blue was used to detect the consumption of L-malate by the appearance of a deep blue
color. In other experiments, M9 minimal medium (32), with either
L-malate or glucose as sole carbon source, was used for
complementation studies. In some experiments, potassium was substituted
for the sodium salts in M9 medium.
Transport Assays in E. coli Vesicles--
RSO membrane vesicles
were prepared by the method of Kaback (33) by shocking spheroplasts in
50 mM Tris-HCl, pH 7.5, plus 2 mM
MgSO4. Everted membrane vesicles were prepared, as
described by others (34), in either 50 mM Tris-HCl, pH 7.5, or 50 mM potassium phosphate, pH 7.5. For some reactions,
the vesicles were preloaded by incubating for 18 h at 4 °C with
the appropriate substrate. Transport of various radioactive substrates
was assayed, by filtration, as described elsewhere (29). Protein was
determined by the method of Lowry et al. (35), using
lysozyme as the standard.
Construction and Characterization of B. subtilis VK3--
A
mutant strain of B. subtilis was constructed in which
yqkI was disrupted with a SpR cassette with its
own promoter. PCR was performed on purified B. subtilis BD99
chromosomal DNA by using primers YqkIUP and YqkIDN that were contained
within the yqkI gene. YqkIUP
(5'-CAAACCAGGTATCGCAGGGAAAGA-3') corresponded to base pairs
265255-265278 of the data base entry (GenBankTM accession number
D84432). YqkIDN (5'-TACCGTCTCCACTTCACCAATATCC-3') corresponded to base
pairs 266899-266867 of the same data base entry. The purified PCR
product was first ligated into HincII-digested pGEM11zf(+)
(ApR; Promega). The recombinant plasmid was selected by
blue/white screening in E. coli DH5a. After isolation, the
yqkI fragment was digested with PmlI, and a gene
encoding SpR was ligated to this linear plasmid, resulting
in a recombinant plasmid containing a fragment of yqkI
disrupted by the SpR gene
(yqkI::SpR). After isolation, the
plasmid was introduced into B. subtilis BD99 by competent
cell transformation. Transformed cells were resistant to Sp (150 µg/ml). Both Southern hybridization and PCR analyses confirmed that
the gene disruption event had taken place in the candidates. The
yqkI-disrupted strain was designated VK3.
 |
RESULTS |
Assays of YufR-dependent Na+/Malate Symport
in RSO Membrane Vesicles of E. coli EP432 and CBT312--
Initial
studies were directed toward determining whether YufR was indeed a
Na+/malate symporter by determining whether the gene
product catalyzed Na+-dependent uptake of
malate and malate-dependent uptake of Na+. RSO
membrane vesicles were prepared from E. coli strains EP432 and CBT312 expressing either the control plasmid pBK36 or pYufR. The
vesicles were pretreated with 10 mM KCN, which was also
present in the assay medium, to inhibit p-dependent
fluxes of malate or Na+. As shown in Fig.
1, substantial uptake of radiolabeled
malate occurred in YufR vesicles of E. coli EP432 in the
presence of Na+ but not in the control vesicles or in the
absence of the Na+ gradient. As shown in Fig.
2, uptake of Na+ by
KCN-treated RSO vesicles of E. coli CBT312/pBK36 was modest and somewhat greater in the absence than in the presence of malate. By
contrast, vesicles prepared from E. coli CBT312/pYufR
exhibited substantial malate-dependent uptake of
22Na+. Taken together, these results supported
the expectation that YufR is a Na+/malate symporter and
would be an appropriate positive control in complementation experiments
with a malate-minus E. coli strain.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 1.
The effect of an inwardly directed
Na+ gradient on uptake of L-malic
acid in RSO membrane vesicles prepared from E. coli
EP432 transformed with plasmid pBK36 or pYufR. RSO membrane
vesicles were pretreated with 10 mM KCN for 10 min.
Transport was initiated by diluting the vesicles 10-fold into a
reaction mixture, at pH 7.5, containing 14 µM
L-[1,4-(2,3)-14C]malic acid (0.8 µCi/ml)
and 10 mM KCN, with or without 10 mM NaCl. Each
reaction mixture contained 100 µg of vesicle protein. Samples were
taken at various times and filtered. The radioactivity was counted by
liquid scintillation spectrometry.
|
|

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 2.
The effect of an inwardly directed malic acid
gradient on 22Na+ uptake by RSO membrane
vesicles prepared from E. coli CBT312 transformed with
plasmid pBK36 or pYufR. The vesicles were treated and assayed in
the presence of KCN as described in the legend to Fig. 1. The vesicles
were diluted into a reaction mixture, at pH 7.5, containing 500 µM 22NaCl (10 µCi/ml), with or without 20 µM L-malic acid, and assayed as in Fig.
1.
|
|
Complementation and Resistance Conferred by YheL, YqkI, YqkIJ, and
YufR--
Although not shown, only YqkIJ and YufR gave a positive
result for complementation of the malate transport-minus phenotype of
E. coli CBT312 in LT medium containing malate; YufR was
further tested, on both solid and liquid media for substrate
specificity, and was found not to support growth on citrate, fumarate,
or succinate. As assessed qualitatively from the blue color that
developed, YufR was slightly more efficacious than YqkIJ in promoting
growth on malate, and neither YqkI nor YheL differed from control
plasmid. As shown in Table II, although
all the transformants grew well on glucose-containing M9 medium,
only YqkIJ and YufR supported growth of E. coli CBT312 on
malate. Growth was dependent on the presence of Na+
in the medium. The results were consistent with YqkI being a malate
uptake system that depended on Na+ and probably also on
adequate lactate, given the requirement for YqkJ.
View this table:
[in this window]
[in a new window]
|
Table II
Growth of various transformants of the malate transport mutant, E. coli CBT312, on malate- or glucose-containing M9 medium and its
dependence upon Na+
|
|
As shown in Fig. 3A, the
Na+ sensitivity of E. coli EP432 in LBK medium
was exacerbated by YufR. In this very undefined rich medium there is
probably enough contaminating malate for this symporter, which mediates
Na+-coupled solute uptake, to take in an inhibitory level
of Na+. The transformants containing these genes were
further examined versus the control transformant in malate-
and glucose-containing media. Although all three transformants were
equally sensitive to growth inhibition by Na+ in
glucose-containing medium (Fig. 3C), YqkI and YqkIJ
conferred significant resistance to Na+ when E. coli EP432 was grown on malate (Fig. 3B). The results of the growth studies were thus consistent with YufR being a
Na+/solute symporter and YqkI being a transporter that
mediates Na+ efflux, which is somehow coupled to a capacity
for malate uptake. Transformation of E. coli EP432 with a
yheL-containing plasmid did not result in substantial
complementation of Na+ sensitivity, as expected for a
relatively high affinity system of the NhaC type (13).

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 3.
The effect of pBK36, pYufR, pYqkI, and pYqkIJ
on the growth of E. coli EP432 on different carbon
sources as a function of NaCl concentration. E. coli
EP432 transformed with pBK36 ( ), pYufR ( ), pYqkI ( ), or pYqkIJ
( ) was grown on LBK medium (A), 50% LBK plus 50 mM K-malate (B), or 50% LBK plus 50 mM glucose (C) in the presence of the indicated
NaCl concentrations. The pH of all the growth media was adjusted to
7.5. The A600 was recorded after 15 h of
growth at 37 °C.
|
|
YqkI- and YheLB-dependent 22Na+
and [14C]Lactate Uptake by Everted Membrane Vesicles of
E. coli EP432--
Uptake of 22Na+ by everted
vesicles made from control, pYheL, and pYqkI transformants of E. coli EP432 was examined as a function of intravesicular malate,
extravesicular lactate, and an electron donor. The everted YheL
vesicles took up 22Na+ when an electron donor
was added, either NADH alone or NADH and lactate, and exhibited no
dependence on intravesicular malate or on the specific presence of
lactate as long as NADH was added. By contrast, the everted YqkI
vesicles exhibited significant 22Na+ uptake,
but only in the presence of both extravesicular lactate and
intravesicular malate (Fig. 4).

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 4.
The effect of an energy source and
intravesicular malic acid on the uptake of
22Na+ by everted membrane vesicles prepared
from E. coli EP432 transformed with pYqkI or
pYheL. Everted membrane vesicles, in buffer at pH 7.5, were either
pre-loaded (closed symbols) or not pre-loaded (open symbols) with 200 µM L-malic acid. They were assayed for
22Na+ uptake in the absence of an energy source
( , ), in the presence of 2.5 mM Tris-NADH ( , ),
or in the presence of NADH plus 200 µM
L-lactic acid ( , ). The control preparation with
pBK36 exhibited no uptake under any condition.
|
|
Because the apparent necessity of extravesicular lactate for
22Na+ uptake by YqkI vesicles made it
impossible to evaluate transport in the absence of an energy source,
inhibitors were employed to probe the energetics of the exchanges
catalyzed by YheL and YqkI. In the experiments shown in Fig.
5A, everted YqkI vesicles of E. coli EP432 were loaded with L-malate and
energized with NADH. The uptake of 22Na+ and
the effect of inhibitors was assayed upon addition of both the
radiolabeled Na+ and extravesicular lactate. The uptake of
22Na+ was markedly inhibited by both CCCP and
nigericin but not by valinomycin. The effect of nigericin is consistent
with an energizing role for the pH component of p. The lack of
inhibition by valinomycin suggests the absence of such a role for
 in the YqkI-mediated antiport. That is, the exchange is likely
to involve movement of one or more protons with the malate and,
overall, to be an electroneutral antiport. In the experiments shown in
Fig. 5B, everted YheL vesicles of E. coli EP432
were assayed for 22Na+ uptake upon being
energized by NADH without any intravesicular malate or extravesicular
lactate. In contrast to the inhibition pattern observed with the
YqkI-mediated exchange, the YheL-mediated Na+/H+ antiport was markedly inhibited by both
valinomycin and CCCP; nigericin inhibited YheL-mediated
Na+/H+ antiport only modestly. The
results are consistent with the YheL-mediated antiport being
electrogenic, as anticipated for a Na+/H+
antiport that plays a role in alkali resistance (8).

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 5.
The effect of ionophores on the uptake of
22Na+ by everted membrane vesicles prepared
from E. coli EP432 transformed with pYqkI or
pYheL. Everted membrane vesicles prepared in 50 mM
potassium phosphate, pH 7.5, were assayed for
22Na+ uptake by energizing with 2.5 mM K-NADH. The YqkI vesicles (A) were preloaded
with 200 µM L-malic acid and were assayed in
the presence of extravesicular L-lactic acid (200 µM). The YheL vesicles (B) were not preloaded
with malic acid and were assayed for 22Na+
uptake in the absence of extravesicular lactic acid. The transport
assays were conducted in the presence of: no further additions ( );
0.1 µM nigericin ( ); 1 µM CCCP ( ); or
1 µM valinomycin ( ).
|
|
The experiments with the mutant E. coli CBT312 directly
supported a role for YqkI in malate transport, and the vesicle
experiments above demonstrated YqkI-mediated Na+ flux.
Direct evidence for YqkI-mediated transport of the lactate via the
putative malate/Na-lactate exchange was then sought by assaying
[14C]lactic acid uptake by everted YqkI vesicles of
E. coli EP432 as a function of the presence of NADH,
intravesicular malate, and extravesicular Na+. In the
absence of added Na+ (Fig.
6A), modest stimulation of
uptake, over a lactate-only reaction mixture, was caused by the
inclusion of NADH and intravesicular malate. By contrast, vesicles
assayed in the "complete" reaction mixture, with intravesicular
malate, extravesicular NADH, Na+, and
[14C]lactate, exhibited impressive uptake of the
labeled transport substrate (Fig. 6B). The rate of antiport
was much higher in the complete mixture than in mixtures from which
either NADH or intravesicular malate was omitted.

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 6.
The effect of extravesicular Na+
and intravesicular malic acid on the uptake of
L-[14C]lactic acid by everted membrane
vesicles prepared from E. coli EP432 transformed with
pYqkI. All reaction mixtures were at pH 7.5 and contained 100 µM L-[(U)14C]lactic acid (1 µCi/ml) as the transport substrate for the assay. In the experiments
shown in A, no Na+ was added to the reaction
mixtures, whereas in the experiments in B, 1 mM
NaCl was added to all the reaction mixtures. Vesicles were either
preloaded with 200 µM L-malic acid
(closed symbols) or not (open symbols). Either no
further additions were made ( , ) or 2.5 mM Tris-NADH
was added as an energy source ( , ).
|
|
The absence of valinomycin inhibition of energized YqkI-mediated uptake
of 22Na+ by everted vesicles suggested that the
antiport might be electroneutral, e.g.
malic 2-2H+/Na+-lactate 1.
If so, energized uptake of [14C]lactate by everted YqkI
vesicles, in the presence of intravesicular malate and extravesicular
Na+, would be inhibited by CCCP and nigericin, which would
abolish the pH. Valinomycin, which abolishes  , would not
inhibit. Stimulation by valinomycin might even be observed with this
substrate if its transport was entirely dependent on YqkI, because the
pH would be elevated upon abolition of the  by valinomycin. As
shown in Fig. 7A, both CCCP
and nigericin indeed inhibited lactate uptake by YqkI vesicles in a
complete reaction mix and valinomycin caused a reproducible stimulation
of lactate uptake. That stimulation supported the conclusion that the
antiport is electroneutral and can be energized by pH, but not by
 . A more direct probe of this conclusion was warranted, because
the antiport catalyzed by some other malolactate antiporters has been
proposed to involve net inward movement of negative charge,
e.g. Hmalate 1 or
malic 2-H+/lactic or
lactate 1-H+ antiport in L. lactis
(24). Perhaps the YqkI-mediated antiport is also an electrogenic
Hmalate 1 or
malic 2-H+/Na+-lactate 1
antiport instead of an electroneutral
malic 2-2H+/Na+-lactate 1
antiport. The stimulatory effect of valinomycin in energized vesicles
might only reflect a dominance of the role of the pH under the
particular assay conditions. To clarify this, YqkI-mediated uptake of
[14C]lactic acid was assayed under de-energized
conditions in cyanide-treated everted vesicles in which uptake was
driven only by the gradients of the solutes. If the antiport were
electrogenic, the  developed during antiport should be a major
constraint on the rate of lactic acid uptake and valinomycin should
stimulate uptake significantly. If the antiport were electroneutral,
valinomycin would be anticipated to have no effect. As shown in Fig.
7B, valinomycin had no effect.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 7.
The effect of ionophores on
[14C]lactic acid uptake by everted membrane vesicles
prepared from E. coli EP432 transformed with
pYqkI. Vesicles prepared in potassium phosphate buffer were
preloaded with 200 µM L-malic acid and
assayed, at pH 7.5 and in the presence of 1 mM NaCl, for
[14C]lactic acid uptake as described in the legend to
Fig. 6. In the experiments shown in A, the vesicles were
energized by the addition of 2.5 mM K-NADH with: no further
additions ( ); 1 µM CCCP ( ); 1 µM
valinomycin ( ); or 0.1 µM nigericin ( ). In the
assays shown in B, vesicles were pretreated and assayed with
10 mM KCN. The transport of [14C]lactic acid
by these de-energized vesicles, which contained intravesicular malate
and had extravesicular Na+, was assayed either with no
further additions ( ) or in the presence of 1 µM
valinomycin ( ).
|
|
The YheL vesicles of E. coli EP432 were, finally, assayed
for [14C]lactate uptake, energized by NADH, that was
dependent on extravesicular Na+ and/or intravesicular
malate. No such uptake was observed, indicating that YheL does not have
a malolactate mode in addition to its malate- and lactate-independent
Na+/H+ antiport activity.
Growth Characteristics of B. subtilis VK3--
Growth studies of
the mutant strain with a disrupted yqkI were conducted in
comparison to the wild type to test the hypothesis that the pathway
might be important for growth on Na-malate, especially when highly
aerobic conditions are compromised by high cell densities or when the
p is directly reduced by inclusion of sublethal protonophore concentrations in the medium. As shown in Fig.
8 for growth up to 10 h, B. subtilis wild type and VK3 grew similarly on glucose or malate
under aerobic conditions in the absence of protonophore. In general,
the growth of the mutant on malate slowed down slightly, relative to
the wild type, after the first few hours of growth. In the presence of
1 or 2 µM CCCP, both strains exhibited a growth lag on
Na-malate. In several independent experiments, the lag was slightly
less pronounced in strain VK3, and the initial rate of growth on malate
in the presence of CCCP was slightly faster in the mutant than in the
wild type strain. However, once growth on malate in the presence of
CCCP commenced in the wild type, it proceeded logarithmically, reaching
the A600 values of 1.4-1.5 shown for the wild
type in the absence of CCCP by 14-18 h. By contrast, growth of VK3 on
malate in the presence of CCCP was arrested when the
A600 of the cultures was only 0.15-0.25. At 2 µM CCCP, the growth turbidity declined thereafter for
several hours at least, whereas at 1 µM CCCP the
turbidity was steady. Although not shown, VK3 did exhibit a very slow
renewed growth on malate after hours of growth arrest in the presence
of CCCP. This may indicate the presence of another system that is
slowly induced and can partially compensate for the role of YqkI. There was no difference in the CCCP effect on growth of the two strains on
glucose.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 8.
Growth of B. subtilis wild
type (BD99) and yqkI-disrupted mutant strain VK3 on
glucose and on malate in the absence and presence of low CCCP
concentrations. The two strains were grown on glucose (open
circles) or malate (closed circles,
triangles)-containing media at 37 °C as described under
"Experimental Procedures." CCCP was added to some cultures at
either 1 µM (open triangles) or 2 µM final concentration (closed triangles). The
A600 was monitored.
|
|
 |
DISCUSSION |
The major findings of the current study are that B. subtilis possesses an antiporter, YqkI, that couples a
malate-lactate exchange to proton uptake and Na+ efflux and
that this transporter plays a role in supporting growth to high density
on malate at reduced protonmotive force. We suggest that
yqkI be designated mleN to reflect its
commonality of function with other malolactate exchangers, and using
the "N" to denote Na+. The coupling of Na+
efflux to such a precursor-product exchange has not been previously reported. The transport data strongly indicate that the MleN-mediated antiport is electroneutral, which further distinguishes it from the
malolactate exchanges reported for both L. lactis (23, 24) and Leuconostoc oenos (25). The simplest MleN-mediated
exchange that is consistent with all the data, and the near neutral pH used in the experiments, would be
malic 2-2H+/Na+-lactate 1
exchange. MLF pathways have been engineered into Saccharomyces cerevisiae strains, e.g. by introducing malate
transport genes from Schizosaccharomyces pombe and the
malolactate enzyme from L. lactis (36, 37), with a view
toward improving the organic acid conversion during fermentation of
grape juice. Perhaps MleN would be useful for fermentations in
preparations with sodium ion concentrations that are above the optimum
for the yeast.
The yqkJ product that is the only other putative product of
an operon, which includes mleN, is strongly predicted to be
a malolactate enzyme that converts malate directly to lactate, as opposed to related malic enzymes that convert malate to pyruvate (38).
The efficacy of YqkJ in providing sufficient cytoplasmic lactate to
support strong malate uptake in E. coli CBT312 supports this
tentative conclusion. Accordingly, we propose the designation mleA for yqkJ. Heretofore, the MLF pathway has
been studied in anaerobes (17-19, 25, 26). Similarly, the other
precursor-product pathways that can generate a p have also been
found in fermentative bacteria (39-42). The finding of an apparent and
novel MLF in B. subtilis is thus intriguing. This MLF
pathway, encompassing the MleN antiport and MleA activity, would result
in net conversion of malate to lactate and CO2, with
concomitant extrusion of Na+ and acidification of the
cytoplasm (uptake of one net proton inasmuch as two protons enter with
malate and one cytoplasmic proton is consumed in the malate-to-lactate
conversion). Because the precursor and product gradients could drive
the transport reaction even at low p, mimicking the protocol with
cyanide-treated vesicles (Fig. 7), we anticipated that cells of
B. subtilis could use this pathway as a malate uptake and
Na+/H+ antiport mode that is relatively
resistant to low oxygen or low p conditions. Increased use of the
MLF pathway might, for example, underlie some of the energetics of
malate-supported growth of protonophore-resistant mutants of B. subtilis in the presence of CCCP (43). The growth studies on
B. subtilis VK3 support this hypothesis and specifically
suggest that malate uptake via MleN (YqkI) is important past the
initial hours of growth when the p has been reduced, e.g.
as done here with protonophores. Similar decreases in p might occur
in various natural environments via suboptimal reductions in
oxygenation or encounters with chaotropic agents, bacteriocins, etc.
The transport reactions catalyzed by two other cation-coupled
transporters have been established in this study. YheL is produced by
the yheL gene, which is part of an operon with one other
gene, yheK, which is strongly predicted to be a regulatory
gene. The experiments in the current study support earlier observations in yheL deletion strains of B. subtilis that
suggested that YheL is a secondary, electrogenic
Na+/H+ antiporter that makes modest
contributions to pH homeostasis in the alkaline range of pH but is not
a contributor to Na+ resistance (14). YheL, despite its
sequence similarity with MleN, did not exhibit a mode of
Na+/H+ antiport that also includes a
malolactate exchange. We propose that the yheKL operon be
designated as nhaXnhaC. Several other genomes in the data
bases, e.g. of Staphylococcus aureus and
Borrelia burgdorferi, contain multiple genes with
significant sequence similarity to the nhaC genes of
Bacillus species. Perhaps in these organisms too, the
paralogous transporters have different activities with some commonality.
Finally, the current studies support the prediction that the
yufR gene product of B. subtilis is a
Na+/malate symporter. The apparent specificity for malate
as the organic acid substrate is also true for the closely related MaeP transporter of Streptococcus bovis, which is part of a
family of transporters that includes citrate transporters CitP and CitS as well as the MleP from L. lactis (24, 26, 44). We propose that yufR be designated maeN to indicate the
demonstrated Na+ coupling of this B. subtilis
malate symporter. maeN is directly upstream of the
mrp operon, which is importantly involved in Na+
resistance in B. subtilis (31). Perhaps yufR and
mrp expression are coordinated under some conditions.
 |
FOOTNOTES |
*
This work was supported by Research Grants GM52837 and
GM28454 from the National Institutes of General Medical Sciences (to T. A. K.) and by The Inoue Enryo Memorial Foundation for Promoting Science (to M. I.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: Box 1020, Dept. of
Biochemistry & Molecular Biology, Mount Sinai School of Medicine, 1 Gustave L. Levy Place, New York, NY 10029. Tel.: 212-241-7280; Fax:
212-241-996-7214; E-mail: terry.krulwich@mssm.edu.
Published, JBC Papers in Press, July 19, 2000, DOI 10.1074/jbc.M001112200
 |
ABBREVIATIONS |
The abbreviations used are:
p, transmembrane
electrochemical proton gradient, conventionally positive and acid out
for a bacterial cell or right-side-out vesicle;
pH, transmembrane pH
gradient;
 , transmembrane electrical potential;
CCCP, carbonyl
cyanide-m-chlorophenylhydrazone;
MLF, malolactate
fermentation;
RSO, right-side-out;
PCR, polymerase chain reaction;
LBK, Luria Broth with KCl instead of NaCl.
 |
REFERENCES |
| 1.
|
Dimroth, P.
(1997)
Biochim. Biophys. Acta
1318,
11-51
|
| 2.
|
Kakinuma, Y.
(1998)
Microbiol. Mol. Biol. Rev.
62,
1021-1045
|
| 3.
| Padan, E., and Krulwich, T. A. (2000) in Bacterial Stress
Responses, eds. Storz, G.& Hengge-Aronis, R., (ASM Press), pp.
117-130
|
| 4.
|
Padan, E.,
and Schuldiner, S.
(1996)
in
The Handbook of Biological Physics
(Konings, W. N.
, Kaback, H. R.
, and Lolkema, J., eds), Vol. II
, pp. 501-531, Elsevier Science, Amsterdam
|
| 5.
|
West, I. C.,
and Mitchell, P
(1974)
Biochem. J.
144,
87-90
|
| 6.
|
Harold, F. M.
(1986)
The Vital Force: A Study of Bioenergetics
, pp. 57-90, W. H. Freeman and Co., New York
|
| 7.
|
Padan, E.,
and Schuldiner, S.
(1994)
Biochim. Biophys. Acta
1185,
129-151
|
| 8.
|
MacNab, R. M.,
and Castle, A. M.
(1987)
Biophys. J.
52,
637-647
|
| 9.
|
Krulwich, T. A.,
Cheng, J.,
and Guffanti, A. A.
(1994)
J. Exp. Biol.
196,
457-470
|
| 10.
|
Krulwich, T. A.,
Guffanti, A. A.,
and Ito, M.
(1999)
in
Bacterial Responses to pH
(Chadwick, D. J.
, and Cardew, R., eds)
, pp. 167-182, John Wiley and Sons, Ltd., Chichester UK
|
| 11.
|
Takami, H.,
and Krulwich, T. A.
(2000)
Extremophiles
4,
19-22
|
| 12.
|
Ivey, D. M.,
Guffanti, A. A.,
Bossewitch, J. S.,
Padan, E.,
and Krulwich, T. A.
(1991)
J. Biol. Chem.
266,
23483-23489
|
| 13.
|
Ito, M.,
Guffanti, A. A.,
Zemsky, J.,
Ivey, D. M.,
and Krulwich, T. A.
(1997)
J. Bacteriol.
179,
3851-3857
|
| 14.
|
Wang, W.,
Guffanti, A. A.,
Wei, Y.,
Ito, M.,
and Krulwich, T. A.
(2000)
J. Bacteriol.
182,
2088-2095
|
| 15.
|
Altschul, S. F.,
Gish, W.,
Miller, W.,
Myers, E. W.,
and Lipman, D. J.
(1990)
J. Mol. Biol.
215,
403-410
|
| 16.
|
Caspritz, G.,
and Radler, F.
(1983)
J. Biol. Chem.
258,
4907-4910
|
| 17.
|
Llokema, J. S.,
Poolman, B. P.,
and Konings, W. N.
(1995)
J. Bioenerget. Biomembr.
27,
467-473
|
| 18.
|
Olsen, E. B.,
Russell, J. B.,
and Henick-Kling, T.
(1991)
J. Bacteriol.
173,
6199-6206
|
| 19.
|
Konings, W. N.,
Lolkema, J. S.,
Bolhuis, H.,
van Veen, H. W.,
Poolman, B.,
and Driessen, A. J. M.
(1997)
Antonie Leeuwenhoek
71,
117-128
|
| 20.
|
Kunkee, R.
(1991)
FEMS Microbiol. Rev.
88,
55-72
|
| 21.
|
Davis, C. R.,
Wibowo, D.,
Fleet, G. H.,
and Lee, T. H.
(1988)
Am. J. Enol. Vitic.
39,
137-142
|
| 22.
|
Henick-Kling, T.
(1995)
J. Appl. Bacteriol.
79,
29-37S
|
| 23.
|
Poolman, B.,
Molenaar, D.,
Smid, E. J.,
Ubbink, T.,
Abee, T.,
Renault, P. P.,
and Konings, W. N.
(1991)
J. Bacteriol.
173,
6030-6037
|
| 24.
|
Bandell, M.,
Ansanay, V.,
Rachidi, N.,
Dequin, S.,
and Lolkema, J. S.
(1997)
J. Biol. Chem.
272,
18140-18146
|
| 25.
|
Labarre, C.,
Guzzo, J.,
Cavin, J.-F.,
and Divies, C.
(1996)
Appl. Environ. Microbiol.
62,
1274-1282
|
| 26.
|
Kawai, S.,
Suzuki, H.,
Yamamoto, K.,
and Kumagai, H.
(1997)
J. Bacteriol.
179,
4056-4060
|
| 27.
|
Pinner, E.,
Kotler, V.,
Padan, E.,
and Schuldiner, S.
(1993)
J. Biol. Chem.
268,
1729-1734
|
| 28.
|
Lo, T. Y. C.,
Rayman, M. K.,
and Sanwal, B. D.
(1972)
J. Biol. Chem.
247,
6323-6331
|
| 29.
|
Guffanti, A. A.,
Cheng, J.,
and Krulwich, T. A.
(1998)
J. Biol. Chem.
273,
26447-26454
|
| 30.
|
Goldberg, E. B.,
Arbel, T.,
Chen, J.,
Karpel, R.,
Mackie, G. A.,
Schuldiner, S.,
and Padan, E.
(1987)
Proc. Natl. Acad. Sci. U. S. A.
84,
2615-2619
|
| 31.
|
Ito, M.,
Guffanti, A. A.,
Oudega, B.,
and Krulwich, T. A.
(1999)
J. Bacteriol.
181,
2394-2402
|
| 32.
|
Ausubel, F. M.,
Brent, R.,
Kingston, R. E.,
Moore, D. D.,
Seidman, J. G.,
Smith, J. A.,
and Struhl, K.
(1994)
Current Protocols in Molecular Biology
, John Wiley and Sons, Inc., New York
|
| 33.
|
Kaback, H. R.
(1971)
Methods Enzymol.
22,
99-120
|
| 34.
|
Ambudkar, S. V.,
Zlotnick, G. W.,
and Rosen, B. P.
(1984)
J. Biol. Chem.
259,
6142-6146
|
| 35.
|
Lowry, O. H.,
Rosebrough, N. H.,
Farr, A. L.,
and Randall, R. J.
(1951)
J. Biol. Chem.
193,
265-275
|
| 36.
|
Bony, M.,
Bidart, R.,
Camarasa, C.,
Ansanay, V.,
Dulau, L.,
Barre, P.,
and Dequin, S.
(1997)
FEBS Lett.
410,
452-456
|
| 37.
|
Volschenk, H.,
Vilijoen, M.,
Grobler, J.,
Petzold, B.,
Bauer, F.,
Subden, R. E.,
Young, R. A.,
Lonvaud, A.,
Denayrolles, M.,
and van Vuuren, H. J. J.
(1997)
Nature Biotechnol.
15,
253-257
|
| 38.
|
Anantharam, V.,
Allison, M. J.,
and Maloney, P. C.
(1989)
J. Biol. Chem.
264,
7244-7250
|
| 39.
|
Abe, K.,
Hayashi, H.,
and Maloney, P. C.
(1996)
J. Biol. Chem.
271,
3079-3084
|
| 40.
|
Molenaar, D.,
Bosscher, J. S.,
TenBrink, B.,
Driessen, A. J. M.,
and Konings, W. N.
(1993)
J. Bacteriol.
175,
2864-2870
|
| 41.
|
Higuchi, T.,
Hayashi, H.,
and Abe, K.
(1997)
J. Bacteriol.
179,
3362-3364
|
| 42.
|
Denayrolles, M.,
Aigle, M.,
and Lonvaud-Funel, A.
(1994)
FEMS Microbiol. Lett.
116,
79-86
|
| 43.
|
Guffanti, A. A.,
Clejan, S.,
Falk, L. H.,
Hicks, D. B.,
and Krulwich, T. A.
(1987)
J. Bacteriol.
169,
4469-4478
|
| 44.
|
Reizer, J.,
Reizer, A.,
and Saier, M. H., Jr.
(1994)
Biochim. Biophys. Acta
1197,
133-166
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
N. J. Shikuma and F. H. Yildiz
Identification and Characterization of OscR, a Transcriptional Regulator Involved in Osmolarity Adaptation in Vibrio cholerae
J. Bacteriol.,
July 1, 2009;
191(13):
4082 - 4096.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Wilks, R. D. Kitko, S. H. Cleeton, G. E. Lee, C. S. Ugwu, B. D. Jones, S. S. BonDurant, and J. L. Slonczewski
Acid and Base Stress and Transcriptomic Responses in Bacillus subtilis
Appl. Envir. Microbiol.,
February 15, 2009;
75(4):
981 - 990.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-W. Youn, E. Jolkver, R. Kramer, K. Marin, and V. F. Wendisch
Identification and Characterization of the Dicarboxylate Uptake System DccT in Corynebacterium glutamicum
J. Bacteriol.,
October 1, 2008;
190(19):
6458 - 6466.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. B. Thomaides, E. J. Davison, L. Burston, H. Johnson, D. R. Brown, A. C. Hunt, J. Errington, and L. Czaplewski
Essential Bacterial Functions Encoded by Gene Pairs
J. Bacteriol.,
January 15, 2007;
189(2):
591 - 602.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Wei, G. Deikus, B. Powers, V. Shelden, T. A. Krulwich, and D. H. Bechhofer
Adaptive Gene Expression in Bacillus subtilis Strains Deleted for tetL.
J. Bacteriol.,
October 1, 2006;
188(20):
7090 - 7100.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Lerondel, T. Doan, N. Zamboni, U. Sauer, and S. Aymerich
YtsJ Has the Major Physiological Role of the Four Paralogous Malic Enzyme Isoforms in Bacillus subtilis
J. Bacteriol.,
July 1, 2006;
188(13):
4727 - 4736.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Sobczak and J. S. Lolkema
The 2-Hydroxycarboxylate Transporter Family: Physiology, Structure, and Mechanism
Microbiol. Mol. Biol. Rev.,
December 1, 2005;
69(4):
665 - 695.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Rodionov, A. G. Vitreschak, A. A. Mironov, and M. S. Gelfand
Comparative genomics of the methionine metabolism in Gram-positive bacteria: a variety of regulatory systems
Nucleic Acids Res.,
June 23, 2004;
32(11):
3340 - 3353.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Tanaka, K. Kobayashi, and N. Ogasawara
The Bacillus subtilis YufLM two-component system regulates the expression of the malate transporters MaeN (YufR) and YflS, and is essential for utilization of malate in minimal medium
Microbiology,
September 1, 2003;
149(9):
2317 - 2329.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Doan, P. Servant, S. Tojo, H. Yamaguchi, G. Lerondel, K.-I. Yoshida, Y. Fujita, and S. Aymerich
The Bacillus subtilis ywkA gene encodes a malic enzyme and its transcription is activated by the YufL/YufM two-component system in response to malate
Microbiology,
September 1, 2003;
149(9):
2331 - 2343.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Herz, S. Vimont, E. Padan, and P. Berche
Roles of NhaA, NhaB, and NhaD Na+/H+ Antiporters in Survival of Vibrio cholerae in a Saline Environment
J. Bacteriol.,
February 15, 2003;
185(4):
1236 - 1244.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. B. Warner and J. S. Lolkema
Growth of Bacillus subtilis on citrate and isocitrate is supported by the Mg2+-citrate transporter CitM
Microbiology,
November 1, 2002;
148(11):
3405 - 3412.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Helmann, M. F. W. Wu, P. A. Kobel, F.-J. Gamo, M. Wilson, M. M. Morshedi, M. Navre, and C. Paddon
Global Transcriptional Response of Bacillus subtilis to Heat Shock
J. Bacteriol.,
December 15, 2001;
183(24):
7318 - 7328.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. P. Krom, R. Aardema, and J. S. Lolkema
Bacillus subtilis YxkJ Is a Secondary Transporter of the 2-Hydroxycarboxylate Transporter Family That Transports L-Malate and Citrate
J. Bacteriol.,
October 15, 2001;
183(20):
5862 - 5869.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Prágai, C. Eschevins, S. Bron, and C. R. Harwood
Bacillus subtilis NhaC, an Na+/H+ Antiporter, Influences Expression of the phoPR Operon and Production of Alkaline Phosphatases
J. Bacteriol.,
April 15, 2001;
183(8):
2505 - 2515.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. L. Brett, Y. Wei, M. Donowitz, and R. Rao
Human Na+/H+ exchanger isoform 6 is found in recycling endosomes of cells, not in mitochondria
Am J Physiol Cell Physiol,
May 1, 2002;
282(5):
C1031 - C1041.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|